Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: Result at the third year of follow-up

Surgery

Volumn 114, Issue 6, 1993, Pages 1097-1102

  Miccoli, Paolo ^a   Antonelli, Alessandro ^a   Iacconi, Pietro ^a   Alberti, Baldassare ^a   Gambuzza, Carmelo ^a   Baschieri, Lidio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; PLACEBO; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SUBSTITUTION THERAPY; THYROIDECTOMY;

AGED; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GOITER; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; THYROID HORMONES; THYROXINE; TREATMENT OUTCOME;

EID: 0027141981     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Endemic goiter and endemic thyroid disorders
2. Suppressive therapy of nontoxic goiter
3. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study
4. Postoperative thyroid hormone therapy in nontoxic goiter
5. Management of goiter and thyroid nodules in an area of endemic goiter
6. Nodular goiter: effects of surgery and thyroxine medication
7. Does prophylactic thyroxine treatment after operation for nontoxic goitre influence thyroid size?
8. Indications for thyroxine therapy after surgery for nontoxic benign goitre
9. Long term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women
10. Monitoring L-thyroxine therapy: lessons from the effects of L-thyroxine on bone density
11. The value of L-thyroxine in the suppressive therapy of euthyroid nodules and in the prevention of post-thyroidectomy recurrences
12. Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter
13. Postoperative goitre recurrence rate in Turkey
14. Recurrence following surgery for benign thyroid nodules
15. Secondary thyroidectomy: a twenty-year experience
16. High resolution real-time sonography of the thyroid
17. Role of neck ultrasonography in follow-up of patients affected by thyroid cancer after surgery
18. Thyroxine suppressive therapy of benign solitary nodules: a perspective randomized study
19. Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy
20. Endemic goiter in the Cauca Valley. 3. Role of serum TSH in goitrogenesis
21. Receptors and receptor-transducing systems in normal and neoplastic human thyroid tissue
22. Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules
23. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid thyroid nodules
24. Long-term thyroxine treatment and bone mineral density
25. Is long-term levothyroxine therapy safe?